Huang Ying 4
4 · Legend Biotech Corp · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
Legend Biotech CEO Huang Ying Sells 5,566 Shares
What Happened
Huang Ying, CEO of Legend Biotech (LEGN), sold 5,566 ordinary shares on 2026-06-25 in an open-market/private sale for a total of approximately $82,265. The reported average price was $14.78 per ordinary share (weighted ADS-equivalent price $29.56). This sale was done to satisfy tax withholding obligations related to the vesting of restricted share units, so it is a routine, tax-related disposition rather than an outright investment decision.
Key Details
- Transaction date: 2026-06-25; Form 4 filed: 2026-06-29 (filed within the 2 business-day reporting window).
- Shares sold: 5,566 ordinary shares; reported average price: $14.78 per ordinary share; total proceeds ≈ $82,265.
- ADS conversion: Each ADS = 2 ordinary shares; sale equals 2,783 ADS with weighted ADS price $29.56. Reported ADS sale prices ranged $28.13–$29.98 (ordinary-share equivalent $14.065–$14.99).
- Footnotes: Sale was to satisfy withholding tax on RSU vesting (tax-withholding transaction). Full per-price breakdown available on request per the filing.
- Shares owned after transaction: Not specified in the provided filing.
Context
This was a tax-withholding sale tied to vested restricted share units (code F in filings), commonly seen after awards vest and generally not read as a directional signal about the executive’s view of the company. The transaction is reported as a sale (S) and was filed timely.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2][F3]2026-06-25$14.78/sh−5,566$82,265→ 241,872 total
Footnotes (3)
- [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.
- [F3]The price reported in Column 4 is a weighted average price and represents the converted sales price of the ADSs of $29.56. The prices sold ranged from $28.13 to $29.98 per ADS (which is equivalent to $14.065 to $14.99 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.